Segment Information

9 Months Ended

Sep. 29, 2018

SEGMENT INFORMATION

Our reporting segments are as follows:


•	CHCA, comprises our U.S., Mexico and Canada consumer healthcare business (OTC, contract manufacturing, infant formula and animal health categories).


•	CHCI, comprises our branded consumer healthcare business primarily in Europe and our consumer focused businesses in the United Kingdom, Australia, and Israel. This segment also includes our U.K. liquid licensed products business.


•	RX, comprises our U.S. Prescription Pharmaceuticals business.

Our segments reflect the way in which our management makes operating decisions, allocates resources and manages the growth and profitability of the Company.

The below tables show select financial measures by reporting segment (in millions):



	Total Assets
	September 29, 2018		December 31, 2017
CHCA	$	3,420.6	$	3,786.8
CHCI	4,823.3		5,029.0
RX	2,699.0		2,813.0
Total	$	10,942.9	$	11,628.8



	Three Months Ended
	September 29, 2018							September 30, 2017
	Net Sales		Operating Income (Loss)			Intangible Asset Amortization		Net Sales		Operating Income (Loss)			Intangible Asset Amortization
CHCA	$	596.2	$	(123.9	)	$	15.3	$	598.8	$	124.3		$	16.9
CHCI	357.6		(2.0		)	48.5		365.4		4.6			50.2
RX	179.3		36.0			20.5		250.6		82.1			21.0
Other	—		—			—		16.5		(0.4		)	0.4
Unallocated	—		(32.1		)	—		—		(48.2		)	—
Total	$	1,133.1	$	(122.0	)	$	84.3	$	1,231.3	$	162.4		$	88.5



	Nine Months Ended
	September 29, 2018							September 30, 2017
	Net Sales		Operating Income (Loss)			Intangible Asset Amortization		Net Sales		Operating Income (Loss)			Intangible Asset Amortization
CHCA	$	1,794.6	$	46.6		$	45.8	$	1,786.4	$	303.6		$	51.1
CHCI	1,140.0		18.4			149.4		1,116.8		8.7			143.4
RX	601.9		154.8			61.6		708.4		239.6			65.6
Other	—		—			—		51.5		9.4			1.2
Unallocated	—		(90.8		)	—		—		(121.7		)	—
Total	$	3,536.5	$	129.0		$	256.8	$	3,663.1	$	439.6		$	261.3